thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

Home » India’s Wait for COVAXIN WHO Approval to End Soon

COVID Vaccines

India’s Wait for COVAXIN WHO Approval to End Soon

TheNewsFacts
Last updated: October 20, 2021 8:59 pm
TheNewsFacts
Share
India's Wait for COVAXIN WHO Approval to End Soon
SHARE

COVAXIN , WHO approval has been the most talked about topic in recent times, and the anxiety levels are up, but what is important to understand is that the process for EUL is taking the normal course with the Bharat Biotech promptly submitting all the information WHO is asking on a rolling basis.

WHO chief Tedros Adhanom Ghebreyesus today discussed in detail the issue of the emergency use listing of Bharat Biotech’s Covid vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

WHO Chief Tedros Discussed in detail about COVAXIN approval with Health Minister Mandaviya

“Had a call with @mansukhmandviya, India’s Health Minister, to discuss #India’s ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India’s support to strengthen WHO, incl. via flexible, sustainable financing,” Ghebreyesus tweeted on Tuesday.

The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: “the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and licence sharing through C-TAP.”

Covid Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable access of Covid health products by boosting their supply.

Mandaviya had also tweeted that he had a “detailed interaction” with the WHO chief, accompanied by other senior officials of the global health agency “on various issues related to health, including pandemic management and WHO reforms.

“DG WHO lauded the mammoth efforts undertaken by the Indian government for #COVID19 vaccination,” Mandaviya tweeted.

The cumulative number of Covid vaccine doses administered in India crossed 99 crore on Tuesday and the country is close to administering 100 crore doses. According to official figures, around 74.45 per cent of India’s eligible adult population has been administered at least one dose of the Covid vaccine and around 30.63 per cent have received both doses.

“We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners – before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” the global health organisation had said in a tweet.

Had a detailed interaction with DG WHO @DrTedros, accompanied by other senior officials of @WHO, on various issues related to health, including pandemic management and WHO reforms.

DG WHO lauded the mammoth efforts undertaken by the Indian government for #COVID19 vaccination.

— Dr Mansukh Mandaviya (@mansukhmandviya) October 19, 2021

WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s Covid vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

“Had a call with @mansukhmandviya, India’s Health Minister, to discuss #India’s ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India’s support to strengthen WHO, incl. via flexible, sustainable financing,” Ghebreyesus tweeted on Tuesday.

The Minister and I also discussed #VaccinEquity issues: the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and license sharing through C-TAP.

— Tedros Adhanom Ghebreyesus (@DrTedros) October 19, 2021

The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: “the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and licence sharing through C-TAP.”

Mandaviya had also tweeted that he had a “detailed interaction” with the WHO chief, accompanied by other senior officials of the global health agency “on various issues related to health, including pandemic management and WHO reforms.

“DG WHO lauded the mammoth efforts undertaken by the Indian government for #COVID19 vaccination,” Mandaviya tweeted.

Had a call with @mansukhmandviya, 🇮🇳 Health Minister, to discuss #India's ongoing #COVID19 vaccination program; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome 🇮🇳's support to strengthen WHO, incl. via flexible, sustainable financing. pic.twitter.com/XhCVIhZBIe

— Tedros Adhanom Ghebreyesus (@DrTedros) October 19, 2021

The cumulative number of Covid vaccine doses administered in India crossed 99 crore on Tuesday and the country is close to administering 100 crore doses. According to official figures, around 74.45 per cent of India’s eligible adult population has been administered at least one dose of the Covid vaccine and around 30.63 per cent have received both doses.

“We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners – before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” the global health organisation had said in a tweet.

“Bharat Biotech – the manufacturer of Covaxin – has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data

Share This Article
Email Copy Link Print
Previous Article Angelina Jolie with kids Dazzle at Eternals Red Carpet Angelina Jolie with kids Dazzle at Eternals Red Carpet
Next Article IndiaJoy 2021, Asia's Biggest Digital Entertainment Festival Opens on 16th Nov IndiaJoy 2021, Asia’s Biggest Digital Entertainment Festival Opens on 16th Nov

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
XFollow
InstagramFollow

Popular Posts

Swiss Woman’s 10-Year Quest to Find Mumbai-Born Biological Mother

Vidhya Philippon, a Swiss woman, has been searching for her biological mother in Mumbai for…

By TheNewsFacts

Padmini Kolhapure Wedding: Surprise Elements We Didn’t Know

Poonam Dhillon has revealed interesting things on how she planned to create Padmini Kolhapure's wedding…

By TheNewsFacts

Where to Cheer, Watch Olympic Games Tokyo 2020 Live?

As the biggest sporting event in the Pandemic era opens, everyone is anxious around the…

By TheNewsFacts

You Might Also Like

COVAXIN Commercialisation Rights In Mexico Given To Ocugen
COVID Vaccines

COVAXIN Commercialisation Rights In Mexico Given To Ocugen

By TheNewsFacts
covaxin
COVID Vaccines

COVAXIN is a Triumph Over COVID-19 Pandemic

By TheNewsFacts
India's COVAXIN, Now Hungarian GMP Certified
COVID Vaccines

India’s COVAXIN, Now Hungarian GMP Certified

By TheNewsFacts
Covaxin booster can defend new variants of concern: ICMR Study
COVID Vaccines

COVAXIN booster can defend new variants of concern: ICMR Study

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?